MD Diagnostics are delighted to be finally exhibiting at a real ERS congress after 3 years. We will be exhibiting the RPCheck, a simple hand held device for measuring MIP, MEP and SNIP. The COCheck range of breath Carbon Monoxide monitors will also be on display. Please come and meet us on stand 8F08.
CO check plus baby CO breath test monitor
RP CHECK – RESPIRATORY PRESSURE METER
Ease of use is key in a busy smoking cessation clinic – from a single breath, the results are instantly displayed in parts per million (PPM) and % carboxyhaemoglobin (%COHb)
ACCURACY IN SMOKING CESSATION – CO Check Plus
European Respiratory Society
Arab Health 2022 Trade show
We are pleased to announce our attendance at Arab Health 2022 Trade show as an online exhibitor. Meet us there, its free to attend.
Our staff will be live to speak to you from 5th January to the 28th February 2022
Great news, we will be exhibiting at the world’s largest medical trade fair Medica Dusseldorf, Germany from November 15th-18th November 202. Our very latest range of CO and Hydrogen monitors, plus Respiratory meters will be on display, we welcome you to join us.
MD Diagnostics Ltd. are delighted to announce the appointment of Numed Healthcare
MD Diagnostics – Numed Healthcare
MD Diagnostics Ltd. are delighted to announce the appointment of Numed Healthcare as our UK distributor for the primary care, dental and emergency care markets. Established in 1990, Numed is a leading supplier of medical devices, also providing comprehensive installation, training, after sales technical support, product servicing and repair services. The company is a very well-known supplier in the primary care equipment market and their highly experienced sales team are now ready to help you with all of your Carbon Monoxide breath testing needs. Call 0114 2433896, email[email protected]or visit the Numed Healthcare websitehttps://www.numed.co.uk/products/category/carbon-monoxide-monitoring
MD Diagnostics expanding and moving to larger premises
We are pleased and excited to announce that from Monday 19th April we will move to larger premises. The move has been possible due to increased sales in the U.K and an increased global footprint as our sales and business partner distribution network continues to expand. Moving to these larger premises will allow us to increase our workforce in the following areas: production, regulatory, R & D, and sales. This is an exciting time as the company expands and moving to the Historic Dockyard in Chatham is a beautiful setting for both the company to be based and for our team to work. Our new address is:
Ease of use is key in a busy smoking cessation clinic – from a single breath the results are instantly displayed in parts per million (PPM) and % carboxyhaemoglobin (%COHb), clear visual guidance is also provided with coloured red, yellow and green indicators dependent on the concentration of exhaled carbon monoxide, indicating if the person is a non-smoker, light smoker, or heavy smoker.
Results instantly displayed
Single press button to toggle between ppm and %COHb
Breath hold countdown timer to guide patients
Coloured light indicators to signify smoking level
Measurement of environmental CO levels
Supplied with Safebreath® mouthpieces to ensure a complete hygiene concept
Additionally the CO Check Pro is also capable of detecting environmental CO levels. When the Environmental Capture is enabled, background CO levels are taken into account when carrying out a breath test. If the background levels are 10ppm for example, then when the person is taking a breath test this background reading of 10ppm will be taken into account, allowing any possible environmental exposure to be clearly identified. Environmental levels are displayed in PPM.
More than a third of Scots report smoking more during lockdown
Figures released from Scottish Government reveal that more than a third (36%) of people who smoke report smoking more during lockdown – with just 8% saying they smoke less. A little over half (56%) of people who smoke reported smoking the same amount.
The 2020 Scottish Health Survey looks at the impact of COVID-19 on people’s mental and physical health including smoking habits.
SafeBreath® filtered disposable cardboard mouthpieces gain in popularity over plastic mouthpieces.
Safebreath(TM) – MD DIagnostics
SafeBreath® filtered mouthpieces have a filter membrane with a bacterial and viral efficacy > 99% and have been independently tested by the Health Protection Agency. More and more healthcare professionals are switching to SafeBreath mouthpieces and this is for numerous reasons:
An increased awareness of infection prevention in all forms of breath testing. Using filters is common practice when performing lung function tests, so why would it not be appropriate when testing patients for breath carbon monoxide tests in smoking cessation or other breath tests?
Many smoking cessation professionals are being guided by their infection prevention leads who actively have encouraged the use of a proven filtered, single patient use, disposable, mouthpiece ensures the greatest level of protection to both patients and devices.
The use of mouthpiece adaptors that can be used for multiple patients or for a set period of time (for example one month) is becoming unpopular for many reasons:
what is the rationale for a monthly time period?
are they truly safe after the first patient has been tested?
additional adaptors are viewed as an additional unnecessary cost
adaptors mean more use of plastic
An increased social and environmental awareness that the use of single use plastics is costly, unnecessary and environmentally damaging. Single use plastics are being stopped by many companies due to their detrimental impact on the environment. SafeBreath mouthpieces use the minimal amount of plastic to achieve maximum patient safety whilst reducing the environmental impact single use plastics have.
Study finds low risk of pregnancy complications from COVID-19
“Pregnant women who test positive for COVID-19 and their newborn babies have a low risk of developing severe symptoms, according to a new study from UT Southwestern.
The study, published today in JAMA Network Open, shows that 95 percent of women who tested positive for COVID-19 during pregnancy had no adverse outcomes. Additionally, the study found that the virus was transmitted to the fetus in just 3 percent of the cases.
Our findings are that approximately 5 percent of all delivered women with COVID-19 infection develop severe or critical illness. Five percent is a major concern when a pandemic is making its way through a population; however, it’s lower than previous reports from the Centers for Disease Control and Prevention (CDC),” says Emily Adhikari, M.D., an obstetrician, gynecologist, and first author of the study. “Most women with asymptomatic or mild infection will be relieved to know that their babies are unlikely to be affected by the virus.”
The researchers set out to measure how COVID-19 infection impacts pregnancy outcomes, how severely ill a pregnant woman gets, placental pathology, and neonatal infections by studying women at Parkland Health and Hospital System — a high-volume prenatal clinic system and public hospital affiliated with UT Southwestern. The team followed 3,374 mothers, 252 of whom tested positive for the virus during pregnancy, from March through August. The group was predominantly Hispanic (75 percent), followed by Black (18 percent) and white (4 percent). There were no significant differences between the expectant mothers in age, number of previous births, BMI, or diabetes.”
COVID-19: 2020 is the International Year of the Midwife
“#Midwives can and do make a huge difference to the lives of women and families. Although 2020 is not the year of celebration originally planned, midwives everywhere should be proud of the potentially life-saving and life-affirming roles they are playing in these adverse circumstances. Keep safe and well, and look after your loved ones and your communities; 2020 is the year when midwives internationally have stepped up to meet this global crisis.”